Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: A pilot study [4]

Journal of Clinical Psychopharmacology

Volumn 23, Issue 1, 2003, Pages 103-104

  Narendran, Rajesh ^a   Young, Carolyn M ^a   Pristach, Cynthia A ^a   Pato, Michele T ^a   Valenti, Antoinette M ^a   Fass, Alice R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE MESILATE; CLOZAPINE; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AGITATION; AKATHISIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; HUMANS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0037309651     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200302000-00018     Document Type: Letter

References (12)

1. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
2. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH. Clinical and biological response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry 1992;49: 345-53.
3. Buchanan RW, Brier A, Kirkpatrick B, Ball P, Carpenter WT. Positive and Negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 1998;155:751-60.
4. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM_ IV Axis I Disorders- Patient Edition (SCID-I/P, Version 2.0, 8/98 revision) Biometrics Research Department 1998, New York State Psychiatric Institute, New York.
5. Dion GL, Tohen M, Anthony WA, Waternaux CS. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 1988;39:652-7.
6. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
7. CGI Clinical Global Impressions: ECDEU Assessment Manual for Psycopharmacology (Revised Edition). Rockville, Md. US Dept of Health, Education and Welfare; 1976:218-22.
8. Kay SR, Opler LA, Lindenmayer J-P. The positive and negative syndrome scale (PANSS): rationale and standardization, Br J Psychiatry. 1989;155:59-65.
9. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212:11-9.
10. Chouinard G, Ross-Chouinard A, Annabel L, Jones BD. The Extrapyramidal Symptom Rating Scale (letter). Can J Neurol Sci 1980; 7:233.
11. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-76.
12. Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 1999;46:73-7.